skip to main content


Search for: All records

Creators/Authors contains: "Yeh, E."

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. null (Ed.)
  2. What this paper adds

    Rituximab appears to control disease in most anti‐myelin oligodendrocyte glycoprotein‐positive patients with relapsing neuroinflammatory disease.

    Rituximab was associated with transitory, mild‐to‐moderate infusion‐related effects.

    Half of patients treated with rituximab developed leukopenia or hypogammaglobulinemia.

    No opportunistic infections were observed.

     
    more » « less